Spots Global Cancer Trial Database for chest radiography
Every month we try and update this database with for chest radiography cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation | NCT05806515 | Prostate Adenoc... Stage IIIB Pros... Stage IIIC Pros... | Biospecimen Col... Carboplatin Chest Radiograp... Computed Tomogr... Magnetic Resona... PSMA PET Scan Surgical Proced... | 18 Years - | SWOG Cancer Research Network | |
| Testing the Addition of an Investigational Drug, Xevinapant, to Usual Radiation Therapy Plus Cisplatin/Carboplatin for Patients With Head and Neck Cancer | NCT06084845 | Head and Neck S... Hypopharyngeal ... Laryngeal Squam... Oral Cavity Squ... Oropharyngeal S... Stage III Cutan... Stage III Hypop... Stage III Laryn... Stage III Lip a... Stage III Oroph... Stage IV Cutane... Stage IV Hypoph... Stage IV Laryng... Stage IV Lip an... Stage IV Oropha... | Biospecimen Col... Carboplatin Chest Radiograp... Cisplatin Computed Tomogr... Image Guided Ra... Intensity-Modul... Magnetic Resona... Positron Emissi... Xevinapant | 18 Years - | Eastern Cooperative Oncology Group | |
| Venetoclax in Combination With Lenalidomide and Dexamethasone (Ven-Rd), Daratumumab and Dexamethasone (Ven-Dd), or Daratumumab-Lenalidomide-Dexamethasone (Ven-DRd) for the Treatment of Multiple Myeloma | NCT06042725 | Multiple Myelom... | Biospecimen Col... Bone Marrow Asp... Bone Marrow Bio... Chest Radiograp... Computed Tomogr... Daratumumab Dexamethasone Lenalidomide Low Dose Comput... Magnetic Resona... Positron Emissi... Venetoclax X-Ray Imaging Questionnaire A... | 18 Years - | Mayo Clinic | |
| Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor | NCT00352534 | Stage I Kidney ... Stage II Kidney... Stage III Kidne... | 3-Dimensional C... Biospecimen Col... Chest Radiograp... Computed Tomogr... Dactinomycin Doxorubicin Hyd... Echocardiograph... Magnetic Resona... Therapeutic Con... Ultrasound Imag... Vincristine Sul... | - 29 Years | Children's Oncology Group | |
| Testing the Safety and Efficacy of the Addition of A New Anti-cancer Drug, ZEN003694, to Chemotherapy Treatment (Etoposide and Cisplatin) for Adult and Pediatric Patients (12-17 Years) With NUT Carcinoma | NCT05019716 | Advanced NUT Ca... Metastatic NUT ... Unresectable NU... | BET Bromodomain... Biopsy Chest Radiograp... Cisplatin Computed Tomogr... Etoposide FDG-Positron Em... Magnetic Resona... Positron Emissi... | 12 Years - | National Cancer Institute (NCI) | |
| Testing the Safety and Efficacy of the Addition of A New Anti-cancer Drug, ZEN003694, to Chemotherapy Treatment (Etoposide and Cisplatin) for Adult and Pediatric Patients (12-17 Years) With NUT Carcinoma | NCT05019716 | Advanced NUT Ca... Metastatic NUT ... Unresectable NU... | BET Bromodomain... Biopsy Chest Radiograp... Cisplatin Computed Tomogr... Etoposide FDG-Positron Em... Magnetic Resona... Positron Emissi... | 12 Years - | National Cancer Institute (NCI) | |
| A Study Using a New Drug, Nivolumab, in Combination With Chemotherapy Drugs to Treat a Type of Cancer Called Nasopharyngeal Carcinoma (NPC) | NCT06064097 | Stage II Nasoph... Stage III Nasop... Stage IV Nasoph... | Biopsy Biospecimen Col... Chest Radiograp... Cisplatin Computed Tomogr... Echocardiograph... Electronic Heal... Fluciclovine F1... Gemcitabine Magnetic Resona... Multigated Acqu... Nivolumab Positron Emissi... Quality-of-Life... Questionnaire A... Radiation Thera... X-Ray Imaging | - 21 Years | National Cancer Institute (NCI) | |
| Evaluating the Impact of Limited Compared With Intense Post-Operative Surveillance on Patient-Reported Outcomes in Patients With Stage II-III Soft Tissue Sarcoma of the Trunk and Extremities | NCT04751409 | Stage II Soft T... Stage III Soft ... Stage IIIA Soft... Stage IIIB Soft... | Chest Radiograp... Computed Tomogr... Follow-Up Follow-Up Imaging Techniq... Questionnaire A... | 18 Years - | M.D. Anderson Cancer Center | |
| Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation | NCT05806515 | Prostate Adenoc... Stage IIIB Pros... Stage IIIC Pros... | Biospecimen Col... Carboplatin Chest Radiograp... Computed Tomogr... Magnetic Resona... PSMA PET Scan Surgical Proced... | 18 Years - | SWOG Cancer Research Network | |
| National Lung Screening Trial (NLST) Screening | NCT00047385 | Lung Cancer | low-dose helica... chest radiograp... | 55 Years - 74 Years | National Cancer Institute (NCI) | |
| Canakinumab for the Prevention of Progression to Cancer in Patients With Clonal Cytopenias of Unknown Significance, IMPACT Study | NCT05641831 | Clonal Cytopeni... | Biospecimen Col... Bone Marrow Asp... Canakinumab Chest Radiograp... Echocardiograph... Placebo Adminis... Quality-of-Life... | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Venetoclax in Combination With Lenalidomide and Dexamethasone (Ven-Rd), Daratumumab and Dexamethasone (Ven-Dd), or Daratumumab-Lenalidomide-Dexamethasone (Ven-DRd) for the Treatment of Multiple Myeloma | NCT06042725 | Multiple Myelom... | Biospecimen Col... Bone Marrow Asp... Bone Marrow Bio... Chest Radiograp... Computed Tomogr... Daratumumab Dexamethasone Lenalidomide Low Dose Comput... Magnetic Resona... Positron Emissi... Venetoclax X-Ray Imaging Questionnaire A... | 18 Years - | Mayo Clinic |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
